Top Markets
Coin of the day
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Rang în acțiuni #33957
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Preț acțiune
$17.15
Ultima sincronizare: 2026-08-03
Capitalizare de piață
$6.51M
Schimbare (1 zi)
9.80%
Schimbare (1 an)
289.77%
Țară
US
Tranzacționează Galera Therapeutics, Inc. (GRTX)

Categorie

Istoricul spliturilor pentru Galera Therapeutics, Inc. (GRTX)
Acțiunea Galera Therapeutics, Inc. (simbol: GRTX) a trecut printr-un total de 1 splituri.
Cel mai recent split a avut loc pe Jul 13, 2026.
O acțiune GRTX cumpărată înainte de Jul 13, 2026 este echivalentă astăzi cu 0.005 acțiuni GRTX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
2026-07-13 1:200 x0.005 x0.005
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE